Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.
Also called NCT05963568
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 1,000 participants
- Registry
-
NCT05963568
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Benin, Ghana, Nigeria, Tanzania
- Registry status
- Recruiting
Technical summary
Registry record NCT05963568. Randomized; single masking; primary purpose prevention. Start 2026-04-01 (actual); primary completion 2029-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)
- Condition
- Stroke
- Condition
- Medication Adherence
- Intervention (Drug)
- Polycap
- Lead sponsor
- Northern California Institute of Research and Education
Record details
- Record id
cardio:ct-nct05963568- Content hash
32ea2c0d3bde52230546d804c436aa39d6f32bf23ef532384559784f101e2100